ResMed RMD
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
Key Insights
ResMed (RMD) Core Market Data and Business Metrics
Latest Closing Price
$223Price-Earnings Ratio
26.33Total Outstanding Shares
146.87 Million SharesDividend
$0.53 Per Share QuarterlySIC Description
Surgical & Medical Instruments & ApparatusPrimary Exchange
New York Stock ExchangeHeadquarters
9001 Spectrum Center Blvd., San Diego, CA, 92123
Historical Stock Splits
If you bought 1 share of RMD before October 3, 2005, you'd have 4 shares today.
| Execution Date | Split Amount |
|---|---|
| August 31, 2010 | 2-for-1 |
| October 3, 2005 | 2-for-1 |
Short Interest
Track Short Interest Levels to Gauge Bearish Market Sentiment and Short Squeeze Potential
| Avg Daily Volume | Days to Cover | Settlement Date | Short Interest |
|---|---|---|---|
| 1,083,181 Shares | 8.06 | 3/14/2025 | 8,726,934 Shares |
| 939,085 Shares | 9.3 | 2/28/2025 | 8,730,591 Shares |
| 1,000,148 Shares | 9.71 | 2/14/2025 | 9,709,488 Shares |
| 1,122,435 Shares | 7.39 | 1/31/2025 | 8,300,270 Shares |
| 778,829 Shares | 10.32 | 1/15/2025 | 8,040,958 Shares |
| 843,810 Shares | 9.37 | 12/31/2024 | 7,908,131 Shares |
Cash Flow Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Net Cash Flow, Continuing | $334.61 Million |
| Exchange Gains/Losses | $-22.91 Million |
| Net Cash Flow From Operating Activities | $1.48 Billion |
| Net Cash Flow From Investing Activities, Continuing | $-114.21 Million |
| Net Cash Flow From Financing Activities | $-1.03 Billion |
| Net Cash Flow From Operating Activities, Continuing | $1.48 Billion |
Income Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Research and Development | $318.83 Million |
| Costs And Expenses | $3.39 Billion |
| Income/Loss From Continuing Operations Before Tax | $1.53 Billion |
| Diluted Earnings Per Share | $8.47 |
| Cost Of Revenue | $2.05 Billion |
| Other Operating Expenses | $44.92 Million |
Comprehensive Income
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Comprehensive Income/Loss Attributable To Parent | $1.16 Billion |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0 |
| Comprehensive Income/Loss | $1.16 Billion |
| Other Comprehensive Income/Loss | $-163.28 Million |
Balance Sheet
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Equity Attributable To Noncontrolling Interest | $0 |
| Other Current Assets | $1.95 Billion |
| Other Non-current Liabilities | $373.51 Million |
| Other Non-current Assets | $3.78 Billion |
| Current Liabilities | $851.96 Million |
| Liabilities And Equity | $7.14 Billion |
Historical Dividends
Current dividend: $0.53 Per Share Quarterly
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| Jan 30, 2025 | Mar 20, 2025 | Feb 13, 2025 | $0.53 | Quarterly |
| Oct 24, 2024 | Dec 12, 2024 | Nov 7, 2024 | $0.53 | Quarterly |
| Aug 1, 2024 | Sep 19, 2024 | Aug 15, 2024 | $0.53 | Quarterly |
| Apr 25, 2024 | Jun 13, 2024 | May 9, 2024 | $0.48 | Quarterly |
| Jan 24, 2024 | Mar 14, 2024 | Feb 8, 2024 | $0.48 | Quarterly |
| Oct 26, 2023 | Dec 14, 2023 | Nov 9, 2023 | $0.48 | Quarterly |